Stephen Hugh Caldwell
University of Virginia · 427 works · 32,658 citations · h-index 80
Top works
- Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease
- Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
- Liver biopsy†
- AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
- A Pilot Study of A Thiazolidinedione, Troglitazone, in Nonalcoholic Steatohepatitis
- The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver diseasePowell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years [Hepatology 1990; 11:74–80]
- Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
- Mitochondrial abnormalities in non-alcoholic steatohepatitis
- Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
- Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds
- Multicenter Study of Lamivudine Therapy for Hepatitis B After Liver Transplantation
- Is NASH underdiagnosed among African Americans?
- Coagulation disorders and hemostasis in liver disease
- IMPROVED OUTCOME OF ORTHOTOPIC LIVER TRANSPLANTATION FOR CHRONIC HEPATITIS B CIRRHOSIS WITH AGGRESSIVE PASSIVE IMMUNIZATION
- Obesity and hepatocellular carcinoma
- Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
- Coagulopathy Does Not Fully Protect Hospitalized Cirrhosis Patients from Peripheral Venous Thromboembolism
- Intensive care of patients with acute liver failure: Recommendations of the U.S. Acute Liver Failure Study Group
- Evidence‐based practice guidelines for plasma transfusion
- Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups